3 Stocks Raising The Health Services Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 8 points (0.0%) at 16,964 as of Wednesday, July 2, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,180 issues advancing vs. 1,847 declining with 143 unchanged.

The Health Services industry currently sits up 0.3% versus the S&P 500, which is unchanged. Top gainers within the industry include Abbott Laboratories ( ABT), up 1.3%, ResMed ( RMD), up 1.2%, Fresenius Medical Care AG & Co. KGaA ( FMS), up 0.8%, WellPoint ( WLP), up 0.7% and Aetna ( AET), up 0.6%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. HCA Holdings ( HCA) is one of the companies pushing the Health Services industry higher today. As of noon trading, HCA Holdings is up $0.99 (1.8%) to $57.08 on light volume. Thus far, 616,686 shares of HCA Holdings exchanged hands as compared to its average daily volume of 2.9 million shares. The stock has ranged in price between $55.73-$57.16 after having opened the day at $55.89 as compared to the previous trading day's close of $56.09.

HCA Holdings, Inc., through its subsidiaries, provides health care services. HCA Holdings has a market cap of $25.1 billion and is part of the health care sector. Shares are up 17.6% year-to-date as of the close of trading on Tuesday. Currently there are 15 analysts who rate HCA Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates HCA Holdings as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow and poor profit margins. Get the full HCA Holdings Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Boston Scientific ( BSX) is up $0.11 (0.8%) to $13.10 on light volume. Thus far, 3.8 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 13.0 million shares. The stock has ranged in price between $12.92-$13.14 after having opened the day at $12.96 as compared to the previous trading day's close of $12.99.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. Boston Scientific has a market cap of $16.9 billion and is part of the health care sector. Shares are up 8.1% year-to-date as of the close of trading on Tuesday. Currently there are 11 analysts who rate Boston Scientific a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Boston Scientific as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, good cash flow from operations and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Boston Scientific Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Baxter International ( BAX) is up $0.54 (0.7%) to $74.30 on average volume. Thus far, 1.2 million shares of Baxter International exchanged hands as compared to its average daily volume of 2.6 million shares. The stock has ranged in price between $73.36-$74.35 after having opened the day at $73.91 as compared to the previous trading day's close of $73.76.

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $39.2 billion and is part of the health care sector. Shares are up 6.0% year-to-date as of the close of trading on Tuesday. Currently there are 4 analysts who rate Baxter International a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, good cash flow from operations, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Baxter International Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Flu Season May Make Hospital Cash Registers Feel Better ... but Maybe Not

Flu Season May Make Hospital Cash Registers Feel Better ... but Maybe Not

3 Healthcare Stocks to Buy After the Market's Beating

3 Healthcare Stocks to Buy After the Market's Beating

Cramer: How to Play the Volatility in UnitedHealth and Others

Cramer: How to Play the Volatility in UnitedHealth and Others

Bitcoin Futures, Hospital Giants Talk Merger - 5 Things You Must Know

Bitcoin Futures, Hospital Giants Talk Merger - 5 Things You Must Know

Healthcare Stocks Mixed as Initial Obamacare Enrollment Higher Than Last Year

Healthcare Stocks Mixed as Initial Obamacare Enrollment Higher Than Last Year